Evotec SE (EVO) Cash from Operations Growth (3y) (2024 - 2026)
Evotec SE (EVO) Cash from Operations Growth (3y) (2024 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 34.90% |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | -9.94% |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 7.32% |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 46.81% |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 27.85% |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -98.15% |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 4.87% |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 111.22% |
| 10 | Evotec SE | 583.10 Mn | 582.58 Mn | - | -106.64% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -106.64% |
| Dec 31, 2025 | -27.04% |
| Sep 30, 2025 | -170.13% |
| Jun 30, 2025 | -45.81% |
| Mar 31, 2025 | -35.15% |
| Dec 31, 2024 | -48.71% |
| Sep 30, 2024 | 24.02% |
| Jun 30, 2024 | -45.76% |
| Mar 31, 2024 | -2,503.50% |